相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda
Amit G. Singal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
β-Catenin Activation in Hepatocellular Cancer: Implications in Biology and Therapy
Yekaterina Krutsenko et al.
CANCERS (2021)
Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling
Mingzhi Han et al.
BRAIN (2020)
KIF18B promotes hepatocellular carcinoma progression through activating Wnt/β-catenin-signaling pathway
Bin Yang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Molecular mechanism of inhibitor bindings to bromodomain-containing protein 9 explored based on molecular dynamics simulations and calculations of binding free energies
Y. Wang et al.
SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2020)
Application of Atypical Acetyl-lysine Methyl Mimetics in the Development of Selective Inhibitors of the Bromodomain-Containing Protein 7 (BRD7)/Bromodomain-Containing Protein 9 (BRD9) Bromodomains
Michael A. Clegg et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
The bromodomain containing protein BRD-9 orchestrates RAD51-RAD54 complex formation and regulates homologous recombination-mediated repair
Qin Zhou et al.
NATURE COMMUNICATIONS (2020)
LAMB3 promotes tumour progression through the AKT-FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer
Zhehui Zhu et al.
ONCOGENE (2020)
The influence of mitochondrial-directed regulation of Wnt signaling on tumorigenesis
Yaritza Delgado-Deida et al.
GASTROENTEROLOGY REPORT (2020)
BRD4/8/9 are prognostic biomarkers and associated with immune infiltrates in hepatocellular carcinoma
Yi-Ru Chen et al.
AGING-US (2020)
Bromodomain inhibitors a decade later: a promise unfulfilled?
Monica M. Mita et al.
BRITISH JOURNAL OF CANCER (2020)
The therapeutic effect of the BRD4-degrading PROTAC A1874 in human colon cancer cells
An-cheng Qin et al.
CELL DEATH & DISEASE (2020)
Bromodomain-containing protein 9 promotes the growth and metastasis of human hepatocellular carcinoma by activating the TUFT1/AKT pathway
Changwei Dou et al.
CELL DEATH & DISEASE (2020)
Cytotoxic activity of bromodomain inhibitor NVS-CECR2-1 on human cancer cells
Seul Gi Park et al.
SCIENTIFIC REPORTS (2020)
Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer
Jia Bian et al.
CELLS (2020)
LncRNA AC010789.1 Promotes Colorectal Cancer Progression by Targeting MicroRNA-432-3p/ZEB1 Axis and the Wnt/β-Catenin Signaling Pathway
Weili Duan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Molecular mechanism study of several inhibitors binding to BRD9 bromodomain based on molecular simulations
Li Ting Song et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
Design, synthesis and biological evaluation of imidazo[1,5-a] pyrazin-8(7H)-one derivatives as BRD9 inhibitors
Peiyuan Zheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
A tRNA fragment, 5′-tiRNAval, suppresses the Wnt/β-catenin signaling pathway by targeting FZD3 in breast cancer
Dongping Mo et al.
CANCER LETTERS (2019)
The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
Ling Wei et al.
MOLECULAR CANCER (2019)
Bromodomain biology and drug discovery
Nilesh Zaware et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
miR-140-3p functions as a tumor suppressor in squamous cell lung cancer by regulating BRD9
Haitao Huang et al.
CANCER LETTERS (2019)
被撤回的出版物: Dickkopf-1 contributes to hepatocellular carcinoma tumorigenesis by activating the Wnt/β-catenin signaling pathway (Retracted article. See vol. 8, 2023)
Rui Zhang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
Nithya Krishnamurthy et al.
CANCER TREATMENT REVIEWS (2018)
DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway
Tong Zhang et al.
CELL DEATH & DISEASE (2018)
The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5
Meng Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation
Brittany C. Michel et al.
NATURE CELL BIOLOGY (2018)
Bromodomain inhibitors and cancer therapy: From structures to applications
Montserrat Perez-Salvia et al.
EPIGENETICS (2017)
BRD9 Inhibition, Alone or in Combination with Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors
Katja F. Kraemer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands
David Remillard et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors
F. Anthony Romero et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway
Yun-yun Peng et al.
CANCER LETTERS (2016)
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
Anja F. Hohmann et al.
NATURE CHEMICAL BIOLOGY (2016)
LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor
Peter G. K. Clark et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
LIVER CANCER Time to evolve trial design after everolimus failure
Josep M. Llovet
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo
X-X He et al.
ONCOGENE (2012)
Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies
Shinji Tanaka et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
